GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (STU:3E0) » Definitions » EBITDA Margin %

Establishment Labs Holdings (STU:3E0) EBITDA Margin % : -21.56% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Establishment Labs Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Establishment Labs Holdings's EBITDA for the three months ended in Sep. 2024 was €-7.8 Mil. Establishment Labs Holdings's Revenue for the three months ended in Sep. 2024 was €36.2 Mil. Therefore, Establishment Labs Holdings's EBITDA margin for the quarter that ended in Sep. 2024 was -21.56%.


Establishment Labs Holdings EBITDA Margin % Historical Data

The historical data trend for Establishment Labs Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings EBITDA Margin % Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -28.50 -29.45 -20.94 -35.08 -35.31

Establishment Labs Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.50 -54.85 -26.82 -22.63 -21.56

Competitive Comparison of Establishment Labs Holdings's EBITDA Margin %

For the Medical Devices subindustry, Establishment Labs Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's EBITDA Margin % falls into.



Establishment Labs Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Establishment Labs Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-53.468/151.443
=-35.31 %

Establishment Labs Holdings's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-7.813/36.245
=-21.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Establishment Labs Holdings  (STU:3E0) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Establishment Labs Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Establishment Labs Holdings Business Description

Traded in Other Exchanges
Address
Coyol Free Zone, Building B15 and 25, Alajuela, CRI
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Establishment Labs Holdings Headlines

No Headlines